Mealey's (May 14, 2021, 9:44 AM EDT) -- MIAMI — Two pharmaceutical companies on April 20 engaged in oral arguments before the 11th Circuit U.S. Court of Appeals over whether the purported false implication that a drug has been approved by the Food and Drug Administration can support a false advertising claim under the Lanham Act....